Altium Capital Management LP Curis Inc Transaction History

Altium Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.71 - $2.43 $383,968 - $1.31 Million	-540,800 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.31 - $5.13 $665,742 - $1.48 Million	-288,200 Reduced 34.76%	540,800 $1.29 Million
Q2 2021 Aug 13, 2021	BUY	$7.45 - $16.27 $424,582 - $927,243	56,991 Added 7.38%	829,000 $6.69 Million
Q1 2021 May 06, 2021	SELL	$8.78 - $12.8 $438,999 - $640,000	-50,000 Reduced 6.08%	772,009 $8.74 Million
Q4 2020 Feb 16, 2021	BUY	$1.08 - $8.2 $887,769 - $6.74 Million	822,009 New	822,009 $6.73 Million

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $332M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of Altium Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Altium Capital Management LP with notifications on news.